Simultaneous Inhibition of Mcl-1 and Bcl-2 Induces Synergistic Cell Death in Hepatocellular Carcinoma

URN to cite this document:: urn:nbn:de:bvb:355-epub-549181
DOI to cite this document:: 10.5283/epub.54918

Michalski, Marlen ; Bauer, Magdalena ; Walz, Franziska ; Tümen, Deniz ; Heumann, Philipp ; Stöckert, Petra Diana ; Gunckel, Manuela ; Kunst, Claudia ; Kandulski, Arne ; Schmid, Stephan

; Müller, Martina ; Gülow, Karsten

License: Creative Commons Attribution 4.0
PDF - Published Version
(2MB)

Date of publication of this fulltext: 25 Oct 2023 12:11

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Despite the recent approval of new therapies, the prognosis for patients with hepatocellular carcinoma (HCC) remains poor. There is a clinical need for new highly effective therapeutic options. Here, we present a combined application of BH3-mimetics as a potential new treatment option for HCC. BH3-mimetics inhibit anti-apoptotic proteins of the BCL-2 family and, thus, trigger the intrinsic ...